Shingles Increases Short-Term Risk of Stroke in Older Adults

A new study in Mayo Clinic Proceedings determined that adults 50 and older are at a 50% increased risk for stroke for 90 days following a shingles episode

Rochester, MN, December 15, 2015

More than 95% of the world’s adult population is infected with the virus that causes chickenpox. Up to one third of these individuals will develop shingles (herpes zoster) in their lifetime. A new U.S. study has found that there is a short-term increased risk of stroke after having shingles, reports Mayo Clinic Proceedings.

Shingles (herpes zoster) is a viral disease caused by reactivation of the chickenpox virus, varicella zoster (VSV), which causes a painful skin rash to erupt in a limited area. Typically, the rash is on one side of the body in a single stripe. It is more common in older adults and those with weak immune systems, but anyone who has had chickenpox can develop shingles. Studies in Europe and Asia have suggested an increased risk of stroke and myocardial infarction (MI) after shingles, but there have not been any previous studies in the U.S.

In the current study investigators assessed the risk of stroke and MI in a U.S. community-based population. About 5,000 adults over 50 in Olmsted County, Minnesota, who had a confirmed episode of shingles, were matched with a group of age- and sex-matched individuals from the same community who had no history of shingles.

The risks for stroke and MI were assessed separately. Patients with a previous stroke were excluded from the stroke analyses, and those with a previous MI were excluded from the MI analyses. The short-term risk of stroke and MI were assessed at three months, six months, one year, and three years after shingles.

“We found there was a 50% increased risk of stroke for three months after shingles, but we also found that people who had shingles had many more risk factors for stroke than those who had not, suggesting they had worse health overall,” explained lead investigator Barbara P. Yawn, MD, MSc, of the Department of Research, Olmsted Medical Center, Rochester, MN. “The bottom line however is that shingles was still associated with an increased risk of stroke for three months afterwards even when we made allowances for these multiple risk and confounding factors.”

Investigators found that the association between shingles and MI at three months was neither strong nor robust across different analytic methods used. “There did appear to be a small increased risk for MI, but when you take other risk factors into consideration, it disappears,” noted Dr Yawn.

There was no increased risk of either stroke or MI at any point beyond three months.

The investigators raise the question of why stroke would be more common after an episode of shingles. “Recent studies have shown that the zoster virus appears to affect vascular tissues as well as the central nervous system and that it may therefore be a systemic illness,” stated Dr. Yawn. “Another possible explanation is that stroke is a consequence of the inflammatory response that occurs with an acute zoster episode. This increased risk of stroke may be preventable by vaccinating against the zoster virus.”

---

Notes for Editor
“Risk of Stroke and Myocardial Infarction After Herpes Zoster in Older Adults in a U.S. Community Population,” by Barbara P. Yawn, MD, MSc; Peter Wollan, PhD; Maria A. Nagel, MD; and Don Gilden, MD. Published in Mayo Clinic Proceedings, Volume 91, Issue 1 (January 2016), http://dx.doi.org/10.1016/j.mayocp.2015.09.015.

Accompanying video available at https://youtu.be/9yvCAYXoFXM.

Full text of this article is also available to credentialed journalists upon request. Contact Rachael Zaleski at 215-239-3658 or mcpmedia@elsevier.com to obtain copies. Journalists wishing to interview lead author Barbara P. Yawn may contact her directly at byawn47@gmail.com.

About Mayo Clinic Proceedings 
The flagship journal of Mayo Clinic and one of the premier peer-reviewed clinical journals in general medicine, Mayo Clinic Proceedings is among the most widely read and highly cited scientific publications for physicians, with a circulation of approximately 125,000. While the Journal is sponsored by Mayo Clinic, it welcomes submissions from authors worldwide, publishing articles that focus on clinical medicine and support the professional and educational needs of its readers. www.mayoclinicproceedings.org

About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research, and education for people from all walks of life. For more information visit www.mayoclinic.org/about and www.mayoclinic.org/news.

About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com

Media contact
Rachael Zaleski
Elsevier
+1 215 239 3658
mcpmedia@elsevier.com